These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 3221792

  • 1. [Immunization against the human immunodeficiency virus in Zaire].
    Zagury D, Salaün JJ, Bernard J, Dechazal L, Goussard B, Lurhuma Z.
    Med Trop (Mars); 1988; 48(4):417-23. PubMed ID: 3221792
    [Abstract] [Full Text] [Related]

  • 2. A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS.
    Zagury D, Bernard J, Cheynier R, Desportes I, Leonard R, Fouchard M, Reveil B, Ittele D, Lurhuma Z, Mbayo K.
    Nature; 1988 Apr 21; 332(6166):728-31. PubMed ID: 3162762
    [Abstract] [Full Text] [Related]

  • 3. Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins.
    Mascola JR, Sambor A, Beaudry K, Santra S, Welcher B, Louder MK, Vancott TC, Huang Y, Chakrabarti BK, Kong WP, Yang ZY, Xu L, Montefiori DC, Nabel GJ, Letvin NL.
    J Virol; 2005 Jan 21; 79(2):771-9. PubMed ID: 15613305
    [Abstract] [Full Text] [Related]

  • 4. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
    Shinoda K, Xin KQ, Kojima Y, Saha S, Okuda K, Okuda K.
    Clin Immunol; 2006 Apr 21; 119(1):32-7. PubMed ID: 16458074
    [Abstract] [Full Text] [Related]

  • 5. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
    Stahl-Hennig C, Coulibaly C, Petry H, Voss G, Dittmer U, Bodemer W, Makoschey B, Jurkiewicz E, Lüke W, Hunsmann G.
    AIDS Res Hum Retroviruses; 1994 Apr 21; 10 Suppl 2():S27-32. PubMed ID: 7865316
    [Abstract] [Full Text] [Related]

  • 6. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A, Lifson JD, Li Z, Jia F, Mukherjee S, Adany I, Liu Z, Piatak M, Sheffer D, McClure HM, Narayan O.
    Virology; 2001 Jan 05; 279(1):241-56. PubMed ID: 11145906
    [Abstract] [Full Text] [Related]

  • 7. Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection.
    Clerici M, Tacket CO, Via CS, Lucey DR, Muluk SC, Zajac RA, Boswell RN, Berzofsky JA, Shearer GM.
    Eur J Immunol; 1991 Jun 05; 21(6):1345-9. PubMed ID: 1845391
    [Abstract] [Full Text] [Related]

  • 8. Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting.
    Richmond JF, Mustafa F, Lu S, Santoro JC, Weng J, O'Connell M, Fenyö EM, Hurwitz JL, Montefiori DC, Robinson HL.
    Virology; 1997 Apr 14; 230(2):265-74. PubMed ID: 9143282
    [Abstract] [Full Text] [Related]

  • 9. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE, Abaitua F, Rodríguez D, Esteban M.
    Virus Res; 2004 Sep 15; 105(1):11-22. PubMed ID: 15325077
    [Abstract] [Full Text] [Related]

  • 10. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH, Lane HC, Folks T, McCoy S, Alter H, Fauci AS.
    J Immunol; 1987 Feb 15; 138(4):1064-7. PubMed ID: 3027168
    [Abstract] [Full Text] [Related]

  • 11. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X, Casimiro DR, Schleif WA, Wang F, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, Heidecker G, Tang A, Chen M, Wilson KA, Gabryelski L, McElhaugh M, Carella A, Moyer C, Huang L, Vitelli S, Patel D, Lin J, Emini EA, Shiver JW.
    J Virol; 2005 Oct 15; 79(19):12321-31. PubMed ID: 16160159
    [Abstract] [Full Text] [Related]

  • 12. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
    Ahmad A, Ladha A, Cohen EA, Menezes J.
    Virology; 1993 Feb 15; 192(2):447-57. PubMed ID: 8421893
    [Abstract] [Full Text] [Related]

  • 13. Adenovirus vectored vaccines.
    Natuk RJ, Davis AR, Chanda PK, Lubeck MD, Chengalvala M, Murthy SC, Wade MS, Dheer SK, Bhat BM, Murthy KK.
    Dev Biol Stand; 1994 Feb 15; 82():71-7. PubMed ID: 7958485
    [Abstract] [Full Text] [Related]

  • 14. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F, Rodríguez JR, Garzón A, Rodríguez D, Esteban M.
    Virus Res; 2006 Mar 15; 116(1-2):11-20. PubMed ID: 16214252
    [Abstract] [Full Text] [Related]

  • 15. A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.
    Perales MA, Schwartz DH, Fabry JA, Lieberman J.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep 01; 10(1):27-35. PubMed ID: 7648281
    [Abstract] [Full Text] [Related]

  • 16. Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.
    Earl PL, Wyatt LS, Montefiori DC, Bilska M, Woodward R, Markham PD, Malley JD, Vogel TU, Allen TM, Watkins DI, Miller N, Moss B.
    Virology; 2002 Mar 15; 294(2):270-81. PubMed ID: 12009868
    [Abstract] [Full Text] [Related]

  • 17. [Randomization of a population for a clinical trial of immunization against the human immunodeficiency virus (HIV)].
    Dechazal L, Goussard B, Salaun JJ, Bernard J, Zagury D.
    Med Trop (Mars); 1988 Mar 15; 48(4):413-6. PubMed ID: 3065586
    [Abstract] [Full Text] [Related]

  • 18. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
    Ahlers JD, Pendleton CD, Dunlop N, Minassian A, Nara PL, Berzofsky JA.
    J Immunol; 1993 Jun 15; 150(12):5647-65. PubMed ID: 8515081
    [Abstract] [Full Text] [Related]

  • 19. T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses.
    Zarling JM, Morton W, Moran PA, McClure J, Kosowski SG, Hu SL.
    Nature; 1993 Jun 15; 323(6086):344-6. PubMed ID: 3093891
    [Abstract] [Full Text] [Related]

  • 20. Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach.
    Tan GS, McKenna PM, Koser ML, McLinden R, Kim JH, McGettigan JP, Schnell MJ.
    Virology; 2005 Jan 05; 331(1):82-93. PubMed ID: 15582655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.